|
Clinicopathological variables
|
Total
|
INPP4B expression
|
p value
|
|---|
|
positive (58)
|
negative (69)
|
|---|
|
Sex
|
0.862
|
|
Male
|
36
|
16
|
20
| |
|
Female
|
91
|
42
|
49
| |
|
Age (y)
|
0.984
|
|
< 68
|
59
|
27
|
32
| |
|
≥ 68
|
68
|
31
|
37
| |
|
Tumor size (cm)
|
0.116
|
|
< 2
|
67
|
35
|
32
| |
|
≥ 2
|
60
|
23
|
37
| |
|
Differentiation
|
0.026
|
|
High/moderate
|
81
|
43
|
38
| |
|
Low/undifferentiated
|
46
|
15
|
31
| |
|
Depth of invasion
|
0.754
|
|
T1/T2
|
39
|
17
|
22
| |
|
T3/T4
|
88
|
41
|
47
| |
|
Lymph node metastasis
|
0.405
|
|
Yes
|
51
|
21
|
30
| |
|
No
|
76
|
37
|
39
| |
|
TNM
|
0.735
|
|
I/II
|
83
|
37
|
46
| |
|
III/IV
|
44
|
21
|
23
| |
|
Gallstones
|
0.321
|
|
Yes
|
84
|
41
|
43
| |
|
No
|
43
|
17
|
26
| |
|
AFP (ug/L)
|
0.999
|
|
< 20
|
122
|
56
|
66
| |
|
≥ 20
|
5
|
2
|
3
| |
|
CEA (ng/ML)
|
0.771
|
|
< 5
|
100
|
45
|
55
| |
|
≥ 5
|
27
|
13
|
14
| |
|
CA199 (U/ML)
|
0.735
|
|
< 37
|
83
|
37
|
46
| |
|
≥ 37
|
44
|
21
|
23
| |
- TNM tumor-node-metastasis, AFP alpha fetoprotein, CEA carcino-embryonic antigen, CA199 carbohydrate antigen 199
- p < 0.05 was defined statistically significant
